- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/10 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 231/10
Total number of patents in this class: 277
10-year publication summary
8
|
15
|
14
|
16
|
15
|
10
|
15
|
8
|
7
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Sharp & Dohme Corp. | 2194 |
9 |
Bayer Cropscience AG | 2035 |
9 |
BASF SE | 20933 |
8 |
Syngenta Crop Protection, LLC | 184 |
7 |
Boehringer Ingelheim International GmbH | 4650 |
6 |
MSD R & D (China) Co. LTD. | 56 |
6 |
Merck Sharp & Dohme LLC | 3748 |
6 |
Toray Industries, Inc. | 6936 |
5 |
Epizyme, Inc. | 370 |
5 |
Sumitomo Chemical Company, Limited | 9046 |
4 |
Astex Therapeutics Limited | 237 |
4 |
Theravance Biopharma R&D IP, LLC | 458 |
4 |
Empirico Inc. | 83 |
4 |
Bristol-myers Squibb Company | 4898 |
3 |
Allergan, Inc. | 2349 |
3 |
Bayer Intellectual Property GmbH | 2499 |
3 |
The United States of America as represented by the Secretary of the Navy | 2745 |
3 |
The Board of Trustees of the Leland Stanford Junior University | 6408 |
3 |
Arena Pharmaceuticals, Inc. | 366 |
3 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 702 |
3 |
Other owners | 179 |